Antiepileptic
Pregnancy: See neurology entry. CONTRAINDICATED unless absolutely necessary.
Sodium Valproate (Epilepsy in Elderly)
Brand names: Epilim Chrono, Episenta
Adult dose
Dose: Elderly: start 200 mg twice daily; titrate to 500–1500 mg/day
Route: Oral (modified-release preferred in elderly)
Frequency: Twice daily (standard); once daily (modified-release)
Max: 2500 mg/day
In elderly, use modified-release formulation for smoother levels. Start low (200 mg BD or 500 mg MR OD). Titrate slowly. MHRA VPPP applies regardless of age for women of childbearing potential. Elderly: encephalopathy risk higher — monitor closely. Avoid abrupt withdrawal.
Paediatric dose
Route: Oral
Frequency: Varies
Max: See neurology entry
See neurology/psychiatry entries for full paediatric dosing.
Dose adjustments
Renal
No specific dose adjustment; monitor clinically.
Hepatic
Contraindicated in hepatic impairment.
Clinical pearls
- In elderly: hyperammonaemic encephalopathy can present as acute confusion — check ammonia and valproate level
- Modified-release (Chrono) preferred in elderly for compliance and tolerability
- Avoid in cognitive impairment — sedation, tremor, and hyperammonaemia are poorly tolerated
- Consider levetiracetam as alternative in elderly — fewer interactions, no monitoring needed
Contraindications
- Hepatic impairment
- Pregnancy (women of childbearing potential without VPPP)
- Mitochondrial disorders
Side effects
- Hyperammonaemic encephalopathy (important in elderly — presents as acute confusion, lethargy)
- Tremor, sedation
- Weight gain
- Hair loss
- Hepatotoxicity
- Hyponatraemia (SIADH less common than with carbamazepine)
Interactions
- Carbapenems — reduce valproate levels significantly (see neurology entry)
- Lamotrigine, meropenem, warfarin — see neurology entry
Monitoring
- Serum valproate level
- Ammonia (if encephalopathy suspected)
- LFTs
- FBC
Reference: BNFc; BNF; NICE CG137; BPS Epilepsy in the Elderly guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5